Asia Pacific Closed System Transfer Devices Market Size, Share & Trends Analysis Report By Type (Membrane-to-Membrane, and Needleless), By Component, By Technology, By Closing Mechanism, By End User, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Closed System Transfer Devices Market would witness market growth of 15.1% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Closed System Transfer Devices Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $195.7 million by 2031. The Japan market is registering a CAGR of 14.5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 15.9% during (2024 - 2031).



Closed system transfer devices find applications across various healthcare settings where the handling of hazardous drugs is prevalent. For instance, oncology settings are among the primary users of CSTDs due to the extensive use of chemotherapy drugs. CSTDs ensure the safe preparation, transfer, and administration of chemotherapy medications, minimizing the risk of exposure to healthcare workers and patients.

Pharmacies that compound sterile preparations utilize CSTDs to maintain sterility and prevent contamination during the compounding process. CSTDs provide a closed system for transferring sterile drugs and ingredients, ensuring the integrity of compounded medications. Compounding pharmacists rely on CSTDs to minimize the risk of microbial contamination and ensure the safety and efficacy of compounded medications.

The increasing cancer rates in China highlight the importance of prioritizing healthcare worker safety, particularly concerning the handling of hazardous drugs. According to the National Library of Medicine, in 2022, China experienced approximately 48,20,000 new cancer cases and 32,10,000 cancer-related deaths, with lung cancer being the most prevalent form of cancer in the country. As cancer rates continue to grow in China, there is a corresponding increase in the demand for chemotherapy as a primary treatment modality. The growing demand for chemotherapy drives the adoption of CSTDs as essential tools for ensuring safe drug preparation, transfer, and administration in Chinese healthcare facilities. In conclusion, the expansion of the medical device industry and high rates of cancer in the region are promoting market growth.

Based on Type, the market is segmented into Membrane-to-Membrane, and Needleless. Based on Component, the market is segmented into Vial access components, Female Components, Male Luers, Bag Spikes, and Others. Based on Technology, the market is segmented into Diaphragm-based devices, Compartmentalized devices, and Air cleaning/filtration devices. Based on Closing Mechanism, the market is segmented into Luer Lock System, Push-to-Turn System, Click-to-Lock System, and Color-to-Color alignment System. Based on End User, the market is segmented into Hospitals & Clinics, Oncology Centers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Becton, Dickinson and Company
• ICU Medical, Inc.
• B.Braun Melsungen AG
• Baxter International, Inc
• Terumo Corporation
• Equashield LLC
• Simplivia Healthcare Ltd.
• CODAN Medizinische Geräte GmbH
• Corning Incorporated
• Vygon SAS

Market Report Segmentation

By Type

• Membrane-to-Membrane
• Needleless

By Component

• Vial access components
• Female Components
• Male Luers
• Bag Spikes
• Others

By Technology

• Diaphragm-based devices
• Compartmentalized devices
• Air cleaning/filtration devices

By Closing Mechanism

• Luer Lock System
• Push-to-Turn System
• Click-to-Lock System
• Color-to-Color alignment System

By End User

• Hospitals & Clinics
• Oncology Centers
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific